Grant: CIHR Fellowship
Direct Payment
$100,000.00
Protective role of plasminogen deficiency in non-alcoholic fatty liver disease and glucose dysmetabolism
EF 2021-22
Résumé
Non-alcoholic fatty liver disease is a growing health problem that affects over 8 million Canadians. Patients with fatty liver disease are more likely to experience liver failure, stroke and heart disease. Currently, there is no approved therapy for fatty liver disease. Identifying the key factors that lead to fatty liver disease will help generate new treatment options. We used an animal model and found that plasminogen (a protein important in clearing blood clots) promotes fatty liver disease in obese mice. In this proposal, I will study how plasminogen influences the development of fatty liver disease. My proposal will identify new treatment strategies for fatty liver disease to help prevent diabetes, stroke, and heart disease and reduce the health burden of fatty liver disease among Canadians.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
North Carolina, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
454697
Name
Hur Woo suk
Region
North Carolina
Country
United States of America
Orgtype
Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Protective role of plasminogen deficiency in non-alcoholic fatty liver disease and glucose dysmetabolism
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Diabetes; Fibrinolysis; Non-Alcoholic Fatty Liver Disease; Non-Alcoholic Steatohepatitis; Obesity; Plasminogen; Thrombosis
Abstract
Non-alcoholic fatty liver disease is a growing health problem that affects over 8 million Canadians. Patients with fatty liver disease are more likely to experience liver failure, stroke and heart disease. Currently, there is no approved therapy for fatty liver disease. Identifying the key factors that lead to fatty liver disease will help generate new treatment options. We used an animal model and found that plasminogen (a protein important in clearing blood clots) promotes fatty liver disease in obese mice. In this proposal, I will study how plasminogen influences the development of fatty liver disease. My proposal will identify new treatment strategies for fatty liver disease to help prevent diabetes, stroke, and heart disease and reduce the health burden of fatty liver disease among Canadians.
Competitiondate
202110
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Hur, Woo suk
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~